|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 178-183, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
M Hachida and DL Morton
The optimum method for lung preservation in preparation for transplantation
remains unresolved. In this study, we evaluated the effectiveness of two
pharmacologic agents for prolonging the preservation time of the ischemic
lung. We compared hydralazine, a vasodilator, and verapamil, which is both
a vasodilator and a calcium channel blocker, in regard to their
effectiveness in promoting functional recovery of the ischemic dog lung in
a new experimental model. The model consists of exposing the left lung of
each dog to normothermic ischemia after clamping the pulmonary artery,
vein, and bronchus. After ischemic periods of 1 to 5 hours, pulmonary
circulation was reestablished. The functional integrity of the left lung
was then evaluated by ligating the right bronchus, so that the dog was
completely dependent on the previously ischemic lung. The left lung of
eight dogs was perfused with 200 ml of Collins-Sachs solution alone in
group A, with Collins-Sachs solution containing 20 mg of hydralazine in
group B (n = 8), and with Collins-Sachs solution containing 5 mg of
verapamil in group C (n = 8). The mean ischemic time was 2.3 hours in group
A, 3.0 hours in group B, and 3.1 hours in group C. One dog in group A
survived after 1 hour of ischemia, two dogs in group B survived after 1 and
3 hours of ischemia, and six dogs in group C survived 2 to 4 hours of
ischemia. Oxygen tension in room air after bronchial ligation was 39.9 +/-
10.2 mm Hg in group A, 59.4 +/- 35.3 in group B, and 76.1 +/- 32.9 in group
C. Statistical significance existed between groups A and C (p less than
0.05). Pulmonary vascular resistance after bronchial ligation was 428.9 +/-
158.8 dynes.sec.cm-5 in group A, 219.9 +/- 51.9 in group B, and 208.3 +/-
84.5 in group C. Thus tissue damage caused by ischemia was significantly
less with verapamil than with the vasodilating drug hydralazine.
ARTICLES
The protection of ischemic lung with verapamil and hydralazine
Division of Surgical Oncology, School of Medicine, University of California, Los Angeles 90024.
This article has been cited by other articles:
![]() |
R. F. Kelly, J. Murar, Z. Hong, D. P. Nelson, F. Hong, A. Varghese, and E. K. Weir Low potassium dextran lung preservation solution reduces reactive oxygen species production Ann. Thorac. Surg., June 1, 2003; 75(6): 1705 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, Q. Wang, X. Zhu, D. Liu, S. Pan, Y. Ruan, and Y. Li Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass Ann. Thorac. Surg., May 1, 2000; 69(5): 1402 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Serrick, A. Jamjoum, A. Reis, A. Giaid, and H. Shennib AMELIORATION OF PULMONARY ALLOGRAFT INJURY BY ADMINISTERING A SECOND RINSE SOLUTION J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1010 - 1016. [Abstract] [Full Text] |
||||
![]() |
Y. Naka, D. K. Roy, H. Liao, N. C. Chowdhury, R. E. Michler, M. C. Oz, and D. J. Pinsky cAMP-Mediated Vascular Protection in an Orthotopic Rat Lung Transplant Model: Insights Into the Mechanism of Action of Prostaglandin E1 to Improve Lung Preservation Circ. Res., October 1, 1996; 79(4): 773 - 783. [Abstract] [Full Text] |
||||
![]() |
Y. Naka, N. C. Chowdhury, H. Liao, D. K. Roy, M. C. Oz, R. E. Michler, and D. J. Pinsky Enhanced Preservation of Orthotopically Transplanted Rat Lungs by Nitroglycerin but Not Hydralazine : Requirement for Graft Vascular Homeostasis Beyond Harvest Vasodilation Circ. Res., May 1, 1995; 76(5): 900 - 906. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |